TY - JOUR
T1 - Walking Speed and Muscle Mass Estimated by the D3-Creatine Dilution Method Are Important Components of Sarcopenia Associated With Incident Mobility Disability in Older Men
T2 - A Classification and Regression Tree Analysis
AU - Osteoporotic Fractures in Men (MrOS) Study Group
AU - Zanker, Jesse
AU - Patel, Sheena
AU - Blackwell, Terri
AU - Duchowny, Kate
AU - Brennan-Olsen, Sharon
AU - Cummings, Steven R.
AU - Evans, William J.
AU - Orwoll, Eric S.
AU - Scott, David
AU - Vogrin, Sara
AU - Cauley, Jane A.
AU - Duque, Gustavo
AU - Cawthon, Peggy M.
N1 - Funding Information:
J.Z. was supported to undertake this research by the Australian and New Zealand Society for Geriatric Medicine Travelling Scholarship, the Australian Institute for Musculoskeletal Science, and was also supported by an Australian Government Research Training Program Scholarship.
Funding Information:
S.B.-O. is supported by a National Health and Medical Research Council (NHMRC, of Australia) Career Development Fellowship ( GNT1107510 , 2016-2019) and a Medicine, Dentistry and Health Sciences (MDHS) Faculty Research Fellowship, University of Melbourne (2020).
Funding Information:
The Osteoporotic Fractures in Men (MrOS) Study is supported by National Institutes of Health funding. The following institutes provide support: the National Institute on Aging (NIA), the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Center for Advancing Translational Sciences (NCATS), and NIH Roadmap for Medical Research under the following grant numbers: U01AG027810 , U01 AG042124 , U01 AG042139 , U01 AG042140 , U01 AG042143 , U01 AG042145 , U01 AG042168 , U01 AR066160 , and UL1 TR000128 . Funding for the D3Cr muscle mass measure was provided by NIAMS (grant number R01 AR065268 ). GlaxoSmithKline provided in-kind support by providing the D 3 -creatine dose and analysis of urine samples.
Funding Information:
D.S. is supported by a National Health and Medical Research Council (NHMRC) Australia RD Wright Biomedical Career Development Fellowship ( GNT1123014 ) and a NHMRC Australia Investigator Grant ( GNT1174886 ).
Funding Information:
Conflicts of interest: T.B. reports salary support from grants from the National Institutes of Health and Merck & Co.
Publisher Copyright:
© 2020 AMDA – The Society for Post-Acute and Long-Term Care Medicine
PY - 2020/12
Y1 - 2020/12
N2 - Objectives: It is unknown whether muscle mass measured by the D3-creatine dilution method is a superior predictor of incident mobility disability than traditional components of sarcopenia definitions (including grip strength, walking speed, appendicular lean mass). The objective of this study was to determine the relative importance of strength; physical performance; and lean, fat, and muscle mass in predicting incident mobility disability in older men. Design: Longitudinal cohort study of participants in the Osteoporotic Fractures in Men (MrOS) study. Setting and Participants: Muscle mass was assessed by D3-creatine dilution in 1098 men (aged 83.7 ± 3.7 years). Participants also completed anthropomorphic measures, 6-m walking speed (m/s), grip strength (kg), chair stands (seconds), and dual x-ray absorptiometry appendicular lean mass (ALM), and total body fat percentage. Men self-reported incident mobility disability defined by the development of an inability to complete at least one of walking 2-3 blocks, climbing 10 steps, or carrying 10 lb over 2.2 ± 0.3 years. Methods: Classification and regression tree analysis was conducted to determine relative variable importance and algorithm cutpoints for predicting incident mobility disability. Given the proximity of walking speed with the primary outcome (mobility disability), analyses were conducted with and without walking speed. Results: Walking speed followed by D3Cr muscle mass/weight were the most important variables (variable importance: 53% and 12%, respectively) in the prediction of self-reported incident mobility disability. D3Cr muscle mass was the most important variable in predicting incident mobility disability when walking speed was excluded, followed by chair stands (variable importance: 35% and 33%, respectively). Body fat percentage, ALM, and grip strength were not selected as nodes in either analysis and had low or negligible variable importance. Conclusions and Implications: This study has provided valuable insights into the importance of different variables in predicting incident mobility disability in older men. Muscle mass by D3Cr may be a key tool for predicting the risk of negative outcomes in older adults in the future, particularly in post-acute and long-term care settings.
AB - Objectives: It is unknown whether muscle mass measured by the D3-creatine dilution method is a superior predictor of incident mobility disability than traditional components of sarcopenia definitions (including grip strength, walking speed, appendicular lean mass). The objective of this study was to determine the relative importance of strength; physical performance; and lean, fat, and muscle mass in predicting incident mobility disability in older men. Design: Longitudinal cohort study of participants in the Osteoporotic Fractures in Men (MrOS) study. Setting and Participants: Muscle mass was assessed by D3-creatine dilution in 1098 men (aged 83.7 ± 3.7 years). Participants also completed anthropomorphic measures, 6-m walking speed (m/s), grip strength (kg), chair stands (seconds), and dual x-ray absorptiometry appendicular lean mass (ALM), and total body fat percentage. Men self-reported incident mobility disability defined by the development of an inability to complete at least one of walking 2-3 blocks, climbing 10 steps, or carrying 10 lb over 2.2 ± 0.3 years. Methods: Classification and regression tree analysis was conducted to determine relative variable importance and algorithm cutpoints for predicting incident mobility disability. Given the proximity of walking speed with the primary outcome (mobility disability), analyses were conducted with and without walking speed. Results: Walking speed followed by D3Cr muscle mass/weight were the most important variables (variable importance: 53% and 12%, respectively) in the prediction of self-reported incident mobility disability. D3Cr muscle mass was the most important variable in predicting incident mobility disability when walking speed was excluded, followed by chair stands (variable importance: 35% and 33%, respectively). Body fat percentage, ALM, and grip strength were not selected as nodes in either analysis and had low or negligible variable importance. Conclusions and Implications: This study has provided valuable insights into the importance of different variables in predicting incident mobility disability in older men. Muscle mass by D3Cr may be a key tool for predicting the risk of negative outcomes in older adults in the future, particularly in post-acute and long-term care settings.
KW - Sarcopenia
KW - aging
KW - mobility
KW - muscle mass
KW - walking speed
UR - http://www.scopus.com/inward/record.url?scp=85084231057&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85084231057&partnerID=8YFLogxK
U2 - 10.1016/j.jamda.2020.03.017
DO - 10.1016/j.jamda.2020.03.017
M3 - Article
C2 - 32381425
AN - SCOPUS:85084231057
SN - 1525-8610
VL - 21
SP - 1997-2002.e1
JO - Journal of the American Medical Directors Association
JF - Journal of the American Medical Directors Association
IS - 12
ER -